+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prostacyclin mimetics afford protection against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice



Prostacyclin mimetics afford protection against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice



Toxicology and Applied Pharmacology 334: 55-65



Prostacyclin (PGI2) serves as a protective, anti-inflammatory mediator and PGI2 mimetics may be useful as a hepatoprotective agent. We examined whether two PGI2 mimetics, ONO-1301 and beraprost, are beneficial in acute liver injury and attempted to delineate the possible mechanism underlying the hepatoprotective effect. Acute liver injury was induced by lipopolysaccharide/d-galactosamine (LPS/GalN) in mice. Mice were given an intraperitoneal injection of PGI2 mimetics 1h before LPS/GalN challenge. Both ONO-1301 and beraprost significantly declined the LPS/GalN-induced increase in serum aminotransferase activity. ONO-1301 and, to a lesser extent, beraprost inhibited hepatic gene expression levels of pro-inflammatory cytokines, which were sharply elevated by LPS/GalN. The hepatoprotective effects of ONO-1301, to a lesser extent, of beraprost were also supported by liver histopathological examinations. The PGI2 receptor antagonist CAY10441 abrogated their hepatoprotective effects. The mechanisms behind the benefit of PGI2 mimetics in reducing LPS/GalN-induced liver injury involved, in part, their suppressive effects on increased generation of reactive oxygen species (ROS), since their ability to prevent LPS/GalN-induced hepatic apoptosis was mimicked by the antioxidant N-acetyl-l-cysteine. They significantly diminished LPS/GalN-induced activation of signal transducers and activators of transcription 3 (STAT3) in liver tissues, an effect which was highly associated with their hepatoprotective effects. We indicate that IP receptor activation with PGI2 mimetics can rescue the damage in the liver induced by LPS/GalN by undermining activation of STAT3 and leading to a lower production of ROS. Our findings point to PGI2 mimetics, especially ONO-1301, as a potential novel therapeutic modality for the treatment of acute liver injury.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060144719

Download citation: RISBibTeXText

PMID: 28887131

DOI: 10.1016/j.taap.2017.09.003


Related references

The Protection of Midazolam Against Immune Mediated Liver Injury Induced by Lipopolysaccharide and Galactosamine in Mice. Frontiers in Pharmacology 9: 1528, 2018

Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice. International Immunopharmacology 56: 105-112, 2018

Dopamine alleviated acute liver injury induced by lipopolysaccharide/d-galactosamine in mice. International Immunopharmacology 61: 249-255, 2018

Esculin prevents Lipopolysaccharide/D-Galactosamine-induced acute liver injury in mice. Microbial Pathogenesis 125: 418-422, 2018

Dexmedetomidine alleviated lipopolysaccharide/D-galactosamine-induced acute liver injury in mice. International Immunopharmacology 72: 367-373, 2019

Oxyresveratrol prevents lipopolysaccharide/ d -galactosamine-induced acute liver injury in mice. International Immunopharmacology 56: 105-112, 2018

Protective mechanisms of wogonoside against Lipopolysaccharide/D-galactosamine-induced acute liver injury in mice. European Journal of Pharmacology 780: 8-15, 2016

Protective Effects of Costunolide Against D-Galactosamine and Lipopolysaccharide-Induced Acute Liver Injury in Mice. Frontiers in Pharmacology 9: 1469, 2018

Maslinic acid protects against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice. Microbial Pathogenesis 119: 49-53, 2018

Protective effects of Asiaticoside on acute liver injury induced by lipopolysaccharide/D-galactosamine in mice. Phytomedicine 17(10): 811-819, 2010

Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice. Journal of Surgical Research 195(2): 522-528, 2015

Protective effect of soyasaponins on acute liver injury induced by D-galactosamine and lipopolysaccharide in mice. Zhongguo Zhong Yao Za Zhi 38(13): 2187-2190, 2013

Early growth response-1 contributes to galactosamine/lipopolysaccharide-induced acute liver injury in mice. American Journal of Physiology. Gastrointestinal and Liver Physiology 293(6): G1124, 2007

Oridonin ameliorates lipopolysaccharide/D-galactosamine-induced acute liver injury in mice via inhibition of apoptosis. American Journal of Translational Research 9(9): 4271-4279, 2017

Critical role of early growth response-1 to galactosamine/lipopolysaccharide-induced acute liver injury in mice. 2007